USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Genome Editing Market Technology (CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), TALEN (Transcriptor-Activator-Like Effector Nuclease), ZFN (Zinc Finger Nucleases), Antisense, Others), By Application (Cell Line Engineering, Genetic Engineering, and Others), and End-User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026

Covid-19

Global Genome Editing Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the genome editing industry. The report analyzes and declares the historical and current trends analysis of the genome editing industry and subsequently recommends the projected trends anticipated to be observed in the genome editing market during the upcoming years.

The genome editing market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire genome editing market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the genome editing industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the genome editing industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the genome editing market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the genome editing industry. The genome editing market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the genome editing sector. Key strategic developments in the genome editing market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the genome editing market are appropriately highlighted in the report.

The global genome editing market is experiencing significant growth that is expected to continue over the upcoming years. A massive rise in the demand for cell line engineering and genetic engineering is likely to act as a key driver of the global genome editing market.

The genome editing market research report delivers an acute valuation and taxonomy of the genome editing industry by practically splitting the market on the basis of different technology, application, end-user, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the genome editing industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the genome editing industry is provided for the leading economies of the world.

The genome editing market is segmented based on technology, application, and end-user. On the basis of technology segmentation, the market is classified into CRISPR (clustered regularly interspaced short palindromic repeats), TALEN (transcriptor-activator-like effector nuclease), ZFN (zinc finger nucleases), antisense, others. In terms of application segmentation, the market is bifurcated into genetic engineering, cell-line engineering, and others. In terms of end-user segmentation, the market is bifurcated into the pharmaceutical and biotechnological companies, academic and research institutes, contract research organizations.

Some of the essential players operating in the genome editing market, but not restricted to include Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Editas Medicine, Horizon Discovery, Integrated DNA Technologies, GenScript, Lonza Group, OriGene Technologies, Sangamo BioSciences, Intellia Therapeutics, Merck, CRISPR Therapeutics and Precision BioSciences, among others.

logoThe taxonomy of the genome editing industry by its scope and segmentation is as follows:

logoGlobal Genome Editing Market: Technology Analysis

  • CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
  • TALEN (Transcriptor-Activator-Like Effector Nuclease)
  • ZFN (Zinc Finger Nucleases)
  • Antisense
  • Others

logo Application Analysis

  • Cell Line Engineering
  • Genetic Engineering
  • Others

logo End-User Analysis

  • Pharmaceutical and Biotechnological Companies
  • Academic and Research Institutes
  • Contract Research Organizations

logo Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Covid-19

Genome Editing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

logoKey Insights from Primary Research

  • As per our primary respondents, the China genome editing market is set to grow annually at a rate of around 16.0%
  • It was established through primary research that the China genome editing market was valued at more than USD 300.00 million in 2019
  • The robust industrialization in China is supposed to display the highest growth in the regional market as it is one of the developed economies.
  • Increase investment in the healthcare sector is supposed to fuel market growth. The companies are supposed to invest in R&D to innovate the better product. Product invention will open new opportunities for the genome editing thus is expected to propel the industry demand in the upcoming years.
  • The “CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)” category, on the basis of technology segmentation, was the leading revenue-generating category accounting for more than 30.0% share, in 2019.
  • The “Cell Line Engineering” category, on the basis of application segmentation, was the leading revenue-generating category accounting for more than 40.0% share, in 2019.
  • The “Pharmaceutical and Biotechnological Companies” category, on the basis of end-user segmentation, was the leading revenue-generating category accounting for more than 40.0% share, in 2019.

logoKey Recommendations from Analysts

  • There is a huge demand for genome editing in developing regions such as the Asia Pacific, which is driving the healthcare industry in the regions.
  • North America region is anticipated to a larger share of the genome editing market in the upcoming years.
  • India's genome editing market is anticipated to rise at the highest rate between 2020 and 2026.
  • Growing at a CAGR around 16.0%, China genome editing and mining market provides numerous opportunities for all of the involved stakeholders across the entire value chain
  • Our analysts have identified “CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)”, “Cell Line Engineering” and “Pharmaceutical and Biotechnological Companies” categories as the leading investment pockets for genome editing market in terms of technology, application, and end-user segmentations respectively

logoGlobal Genome Editing Market Revenue Share in 2019 – By End-User

logoGenome Editing Market

Covid-19

Genome Editing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  •  Transposagen Biopharmaceuticals
  •  Thermo Fisher Scientific
  •  Editas Medicine
  •  Horizon Discovery
  •  Integrated DNA Technologies
  •  GenScript
  •  Lonza Group
  •  OriGene Technologies
  •  Sangamo BioSciences
  •  Intellia Therapeutics
  •  Merck
  •  CRISPR Therapeutics 
  •  Precision BioSciences

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Genome Editing Market.
According to Facts and Factors research report, the global Genome Editing Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Genome Editing Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Genome Editing Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Genome Editing Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Cold Plasma Market Report 2022-2028

[201+ Pages Report] According to Facts and Factors, the global cold plasma market was worth USD 1.8 billion in 2021 and is expected to grow to USD 3.5 billion by 2028, growing at a 16.2% CAGR between 2022 and 2028. The global cold plasma market report provides a comprehensive analysis of the marke...

Published Date : 11-May-2022 | | Category : | Pages : 201 | Format : Read more

Inquiry for Buying Request Sample
report img

Etanercept Market Report 2022-2028

[221+ Pages Report] According to Facts and Factors, during the forecast period of 2022 to 2028, the global etanercept market is estimated to develop at a compound annual growth rate (CAGR) of 3.3%. The global etanercept market was worth USD 15.5 billion in 2021, and it is anticipated to exceed USD...

Published Date : 26-Apr-2022 | | Category : | Pages : 221 | Format : Read more

Inquiry for Buying Request Sample